110 related articles for article (PubMed ID: 19487168)
1. Segmental colitis associated with diverticula: a rare clinical entity and a new challenge for the gastroenterologist.
Ierardi E; Hassan C; Zullo A; De Francesco V; Valle ND; Prencipe S; Rosania R; Morini S; Panella C
Dig Liver Dis; 2009 Nov; 41(11):794-7. PubMed ID: 19487168
[TBL] [Abstract][Full Text] [Related]
2. Tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis down-regulates after treatment.
Tursi A; Elisei W; Brandimarte G; Giorgetti GM; Inchingolo CD; Nenna R; Ierardi E
J Gastrointestin Liver Dis; 2011 Dec; 20(4):365-70. PubMed ID: 22187701
[TBL] [Abstract][Full Text] [Related]
3. Segmental colitis associated with diverticula: a prospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII).
Imperiali G; Meucci G; Alvisi C; Fasoli R; Ferrara A; Girelli CM; Rocca F; Saibeni S; Minoli G
Am J Gastroenterol; 2000 Apr; 95(4):1014-6. PubMed ID: 10763952
[TBL] [Abstract][Full Text] [Related]
4. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
5. Segmental colitis associated with diverticular disease and other IBD look-alikes.
Harpaz N; Sachar DB
J Clin Gastroenterol; 2006 Aug; 40 Suppl 3():S132-5. PubMed ID: 16885696
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel diseases: controversies in the use of diagnostic procedures.
Vucelic B
Dig Dis; 2009; 27(3):269-77. PubMed ID: 19786751
[TBL] [Abstract][Full Text] [Related]
7. Musosal tumour necrosis factor α in diverticular disease of the colon is overexpressed with disease severity.
Tursi A; Elisei W; Brandimarte G; Giorgetti GM; Inchingolo CD; Nenna R; Picchio M; Giorgio F; Ierardi E
Colorectal Dis; 2012 May; 14(5):e258-63. PubMed ID: 22469482
[TBL] [Abstract][Full Text] [Related]
8. Ankylosing spondylitis and bowel disease.
Rudwaleit M; Baeten D
Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):451-71. PubMed ID: 16777576
[TBL] [Abstract][Full Text] [Related]
9. Tumour necrosis factor alpha down-regulation parallels inflammatory regression in ulcerative colitis patients treated with infliximab.
Hassan C; Ierardi E; Burattini O; De Francesco V; Zullo A; Stoppino G; Panella C; Morini S
Dig Liver Dis; 2007 Sep; 39(9):811-7. PubMed ID: 17652038
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of segmental colitis associated with diverticulosis.
Koutroubakis IE; Antoniou P; Tzardi M; Kouroumalis EA
Int J Colorectal Dis; 2005 Jan; 20(1):28-32. PubMed ID: 15316721
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory manifestations at colonoscopy in patients with colonic diverticular disease.
Tursi A; Elisei W; Giorgetti GM; Aiello F; Brandimarte G
Aliment Pharmacol Ther; 2011 Feb; 33(3):358-65. PubMed ID: 21133960
[TBL] [Abstract][Full Text] [Related]
12. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
[TBL] [Abstract][Full Text] [Related]
13. Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease.
Yantiss RK; Odze RD
Am J Gastroenterol; 2007 Apr; 102(4):890-904. PubMed ID: 17324129
[TBL] [Abstract][Full Text] [Related]
14. [Biological drugs in inflammatory bowel disease. Valuable supplement--but only when conventional therapy is not sufficient].
Hellström PM; Schmidt D; Karlén P
Lakartidningen; 2007 Oct 10-16; 104(41):2973-6. PubMed ID: 17977308
[No Abstract] [Full Text] [Related]
15. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
16. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
Hibi T; Inoue N; Ogata H; Naganuma M
J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis as a therapeutic tool in IBD?
Lügering A; Lebiedz P; Koch S; Kucharzik T
Ann N Y Acad Sci; 2006 Aug; 1072():62-77. PubMed ID: 17057191
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
[TBL] [Abstract][Full Text] [Related]
19. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
20. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
